Abstract |
A newly developed human immunoglobulin for intravenous use, SM-4300, purified by cold ethanol precipitation and ion exchange resin, has been studied in the surgery. SM-4300 has been evaluated clinically against inpatients with severe bacterial and/or fungal infections in the combined use with the antibiotics which were resistant to antibiotic therapy. Total number of 13 patients affected with various severe infections were treated with SM-4300. Clinical effects of SM-4300 were excellent in 2 cases, good in 6, fair in 3 and poor in 2. The efficacy rate was summarized as 61.5%. No subjective and objective clinical side effects and abnormal laboratory findings were observed. In conclusion, combination therapy with SM-4300 and antibiotics was considered to be safe and effective against severe bacterial and/or fungal infections in the surgery.
|
Authors | J Ota, N Ueda, Y Kimoto, Y Tsukahara, M Fujita, T Taguchi, T Okumura, K Tomita, M Kimura |
Journal | The Japanese journal of antibiotics
(Jpn J Antibiot)
Vol. 38
Issue 9
Pg. 2638-46
(Sep 1985)
ISSN: 0368-2781 [Print] Japan |
PMID | 4079029
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Immunoglobulins
- Ion Exchange Resins
- SM-4300
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Bacterial Agents
(administration & dosage)
- Bacteria
(immunology)
- Bacterial Infections
(therapy)
- Child
- Drug Evaluation
- Drug Resistance, Microbial
- Drug Therapy, Combination
- Female
- Humans
- Immunization, Passive
- Immunoglobulins
(administration & dosage)
- Ion Exchange Resins
- Male
- Middle Aged
- Mycoses
(therapy)
- Postoperative Complications
(therapy)
- Surgical Wound Infection
(therapy)
|